跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMIGRAN 20 MG SOLUCION PARA PULVERIZACION NASAL. - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMIGRAN 20 MG SOLUCION PARA PULVERIZACION NASAL.
Approved
STANDARD
IMIGRAN 20 MG SOLUCION PARA PULVERIZACION NASAL.
Glaxosmithkline (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 21, 2022
Approval ID
f65ccbd995cef0f1
Company
Glaxosmithkline (Ireland) Limited
Type
Standard
Approval Details
Approval Id
f65ccbd995cef0f1
Drug Cima Aemps Name
IMIGRAN 20 MG SOLUCION PARA PULVERIZACION NASAL.
Register Number
3314999C
Holder Company Name
Glaxosmithkline (Ireland) Limited
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/glaxosmithkline-ireland-limited
Authorization Date
2022-11-21
Dosage Form
SOLUCION PARA PULVERIZACION NASAL
Dose
20 mg
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glaxosmithkline (Ireland) Limited
Company Detail Path
/organization/glaxosmithkline-ireland-limited
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE (IRELAND) LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
12 RIVERWALK
Active Ingredients
SUMATRIPTAN
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 21, 2022
Approval ID
f65ccbd995cef0f1
Type
Standard
Back to CIMA-AEMPS Approvals
